The burden of recurrent depression: causes, consequences, and future prospects.

Depression represents one of the most profound human problems currently facing the global health care system. It is a prevalent clinical condition and is estimated to rival virtually every other known medical illness in burden of disease morbidity early in this millennium. Understanding the chronic nature of this illness is key to the development of a more informed, longitudinal perspective on the diagnosis and treatment of depression. In this report, the morbid impact of depression is reviewed, from the perspectives of illness symptoms, societal impact, and emerging evidence of critical neurobiological consequences of the untreated condition. Reconceptualizing major depression from this longitudinal and multidimensional perspective is crucial to providing an effective response to this critical public health challenge.

[1]  D J Kupfer,et al.  Long-term treatment of depression. , 1991, The Journal of clinical psychiatry.

[2]  R. Kessler,et al.  Epidemiology of DSM‐III‐R major depression and minor depression among adolescents and young adults in the national comorbidity survey , 1998, Depression and anxiety.

[3]  James R MacFall,et al.  Hippocampal volume in geriatric depression , 2000, Biological Psychiatry.

[4]  U. Bergman,et al.  Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. , 1999, Journal of affective disorders.

[5]  D R Offord,et al.  Epidemiology of childhood depressive disorders: a critical review. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  R. Dunn,et al.  Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines , 1999, Journal of psychopharmacology.

[7]  E. Berndt,et al.  Depression: a neglected major illness. , 1993, The Journal of clinical psychiatry.

[8]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[9]  M. Thase,et al.  Lost human capital from early-onset chronic depression. , 2000, The American journal of psychiatry.

[10]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[11]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Tangen,et al.  Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans , 2000 .

[13]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[14]  G. Fenton,et al.  Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland , 1996, British medical journal.

[15]  J. Markowitz,et al.  Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. , 1999, Journal of affective disorders.

[16]  David Goldberg,et al.  The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.

[17]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[18]  W. Coryell,et al.  Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. , 1999, The American journal of psychiatry.

[19]  A. Leon,et al.  Recovery, chronicity, and levels of psychopathology in major depression. , 1996, The Psychiatric clinics of North America.

[20]  S. Southwick,et al.  MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. , 1995, The American journal of psychiatry.

[21]  B. Druss,et al.  Health and disability costs of depressive illness in a major U.S. corporation. , 2000, The American journal of psychiatry.

[22]  Elizabeth Gould,et al.  Stress and hippocampal neurogenesis , 1999, Biological Psychiatry.

[23]  M. Bourassa,et al.  Gender, depression, and one-year prognosis after myocardial infarction. , 1999, Psychosomatic medicine.

[24]  M. Watson,et al.  Influence of psychological response on survival in breast cancer: a population-based cohort study , 1999, The Lancet.

[25]  M. Keller,et al.  Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression , 1998, Biological Psychiatry.

[26]  J. Mccombs,et al.  The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. , 1990, The Journal of clinical psychiatry.

[27]  D. Pine,et al.  Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? , 1999, The American journal of psychiatry.

[28]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[30]  M. Thase,et al.  The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. , 1997, JAMA.

[31]  E Frank,et al.  Cost utility analysis of maintenance treatment for recurrent depression. , 1992, Controlled clinical trials.

[32]  D. Spiegel Cancer and Depression , 1996, British Journal of Psychiatry.

[33]  B. Mcewen,et al.  Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Price,et al.  Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders , 1998, Molecular Psychiatry.

[35]  W. Katon,et al.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. , 1999, Archives of general psychiatry.

[36]  J. Lépine,et al.  Depression in the community: the first pan‐European study DEPRES (Depression Research in European Society) , 1997, International clinical psychopharmacology.

[37]  Neural plasticity to stress and antidepressant treatment , 1999, Biological Psychiatry.

[38]  Elizabeth Gould,et al.  Regulation of hippocampal neurogenesis in adulthood , 2000, Biological Psychiatry.

[39]  Klaus P. Ebmeier,et al.  Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression , 1998, British Journal of Psychiatry.

[40]  L. Magliano,et al.  Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. , 1992, The American journal of psychiatry.

[41]  J. Mintz,et al.  Treatments of depression and the functional capacity to work. , 1992, Archives of general psychiatry.

[42]  M. B. Walker,et al.  Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. , 1999, European journal of cancer.

[43]  D. Pine,et al.  The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. , 1998, Archives of general psychiatry.

[44]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[45]  S. Watson,et al.  Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.